source
- Scribe targets $96 million from Nasdaq IPO as Scholar Rock awaits site classification for apitegromabScribe, a gene-editing biotech, announced plans for a Nasdaq initial public offering that could raise roughly $96 million. The company said it would price the shares at $14 each, which is the midp…
- Australia's TGA opens consultation to revamp rules for digital mental health toolsThe Therapeutic Goods Administration (TGA) has launched a public consultation aimed at updating the regulatory framework that governs digital mental health tools in Australia. The move seeks to cla…